No replies to this topic

[Woof1]

Found this by accident whilst going over my investment portfolio.
Didn't even knew such things existed.
Might be of interest for those High curved LB's

Auxilium Pharmaceuticals (NASDAQ:AUXL) Stock Climbs on Xiaflex Results – AUXL, BSTC, WPI, ABT

Posted on June 5, 2012 by Thomas Vedder


Auxilium Pharmaceuticals, Inc (NASDAQ:AUXL) stock moved up on Monday after the corporation reported that its drug Xiaflex worked as a treatment for a situation that causes curvature of the penis and makes sex difficult.

Xiaflex was earlier accepted in 2010 as a treatment for Dupuytren’s contracture. Auxilium is also trailing the medicine as a treatment for Peyronie’s disease, which is rooted by development of scar tissue that can harden and curve the penis.

The corporation reported that the drug lowered that abnormal curvature in 2 late-stage clinical examinations.

Shifting readers focus to broader market, let’s consider market performance of other stocks that significantly affect same sector. BioSpecifics Technologies Corp. (NASDAQ:BSTC) increased +5.20% to settle at $17.00, Watson Pharmaceuticals, Inc. (NYSE:WPI) moved down -1.03% to end at $69.03 while Abbott Laboratories (NYSE:ABT) plunged -0.50% to finish on Monday at $60.22.

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) on June 04, 2012 increased +16.23% to the closing price of $21.91. The overall volume in the last trading session was 5.99 million shares. Its fifty two week range was $13.59-$22.55. The total market capitalization remained $1.06 billion.

AUXL is ahead its 52 week low with +61.22% and going down from its 52 week high price with -2.84%. AUXL last month stock price volatility remained 3.86%. In its share capital AUXL has 48.38 million outstanding shares among them 47.32 million shares have been floated in market exchange. AUXL stock institutional ownership remained 99.00% while insider ownership included 0.13%.

The stock price of AUXL is moving forward from its 20 days moving average with +18.59% and remote positively from 50 days moving average with +19.60%. AUXL current year earnings per share experienced an addition with +36.37% while its current quarter performance remained +9.00%. Company’s beta coefficient included 0.70. Beta factors measures the amount of market risk associated with market trade.